WhitTier Trust Company’s Emergent Biosolutions EBS Stock Holding History

WhitTier Trust Company’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83	Buy	+10	New	+$84	﹤0.01%	1409

Other funds holding EBS

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

VFA

Values First Advisors Gray, Tennessee $219M AUM 33.35% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

KFGK

Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

BWM

Baron Wealth Management Troy, Michigan $386M AUM 30.18% 1-Year Est. Return

WhitTier Trust Company's EBS Position: Q2 2026 in Review

WhitTier Trust Company opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 10 shares worth $83. The stake represents ﹤0.01% of the portfolio and ranks #1409 among its holdings.

36 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

WhitTier Trust Company held 10 shares of Emergent Biosolutions worth $83 as of Q2 2026.
Emergent Biosolutions was a new WhitTier Trust Company position in Q2 2026.
Emergent Biosolutions made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1409 holding.
36 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.